NCT05019430 - Cocaine and Zolmitriptan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

January 9, 2025

Study Completion Date

January 9, 2025

Conditions

Cocaine Use Disorder

Interventions

DRUG

Cocaine

The pharmacodynamic effects of cocaine will be determined during maintenance on placebo and zolmitriptan.

DRUG

Placebo oral capsule

The pharmacodynamic effects of placebo will be determined.

DRUG

Zolmitriptan

The pharmacodynamic effects of zolmitriptan maintenance will be determined.

Trial Locations (1)

University of Kentucky, Lexington

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

William Stoops

OTHER